ASX-Dividend-Report-Banner

89th CMEF in Shanghai Elevates Global Medical Device Trade to The Next Level

April 15, 2024 11:00 PM AEST | By Cision
 89th CMEF in Shanghai Elevates Global Medical Device Trade to The Next Level
Image source: Kalkine Media

SHANGHAI, April 15, 2024 /PRNewswire/ -- The 89th edition of the China International Medical Equipment Fair (CMEF) witnessed an impressive turnout of over 200,000 attendees from more than 150 countries. Prominent companies in the industry seized the opportunity to showcase their cutting-edge products and comprehensive solutions, covering every aspect of the industry chain. The exhibition served as a dynamic platform for collaboration, innovation, and exploration, significantly boosting global medical device trade.

CMEF, over four decades, has grown into a multifaceted expo for the medical device industry, featuring innovation showcases, commercial trade, and knowledge exchange. It provides a key platform for launching and promoting advanced medical technologies and products.

This year, the exhibition featured nearly 5,000 renowned global enterprises with flagship products on display. Diverse categories were designed to explore emerging trends and prospects. Key categories include:

  • Medical Robotics: This year, it showcased multiple China's homegrown new products, including a four-arm robotic surgical system approved for clinical use in complex procedures covering the thoracic, abdominal, and pelvic regions.
  • High-end Medical Devices: A variety of innovative equipment was on display. For example, the apex platform, equipped with technologies throughout the imaging chain, offers an effortless workflow model of efficiency to assist in handling imaging challenges.
  • AI-enabled healthcare digitization: More companies are integrating technologies such as artificial intelligence, big data analysis, and machine learning, to provide healthcare diagnosis and treatment with deeper insights and intelligent decision support. For example, the Chest CT AI solution utilizes AI-powered assistance to analyze chest CT images, streamlining the process and enhancing the efficiency and diagnostic accuracy for doctors.

This year, CMEF kicked off on April 11th, coinciding with World Parkinson's Day and broadening new horizons in diagnosing and treating this disease. For example, Siemens unveiled their latest innovation, the MAGNETOM Cima.X. With Gemini Gradients featuring 2001 mT/m at 200 T/m/s, it delivers unparalleled whole-body performance.  GE Healthcare also brought their high-end all-digital PET/CT product, which can improve photon collection efficiency by 60%, allowing clinical practitioners to obtain high-definition, low-dose images with ultra-high unit sensitivity. It aids in the early diagnosis of Parkinson's disease and assessment of cognitive impairments.

In 2023, China's medical device sector saw a 9.34% average growth rate in trade, with exports growing by 8.21% and imports increasing by 10.79%. Import values of medical equipment and IVD products exceeded exports. On March 13th, the State Council officially launched a new round of large-scale equipment upgrades and trade-ins for consumer goods. The initiative emphasizes the need to encourage eligible medical institutions to accelerate the upgrading and transformation of medical equipment.

CMEF, as a global platform for trade cooperation, enables international exchanges, fostering cross-border trade, and supports multilateral collaborations in diverse sectors. It attracts participants from over 30 countries and regions, catalyzing technological and trade exchanges and supporting enterprises in accessing global markets. The upcoming exhibition is scheduled to take place in Shenzhen from October 12th to 15th, 2024.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.